Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014).

about

Melanocortin-4 receptor-regulated energy homeostasis Latest approaches for the treatment of obesity.Neuroendocrinology: New hormone treatment for obesity caused by POMC-deficiency.

P2860

Q37593898-DCDCC9DD-55EF-4A03-9175-50A568A6B471 Q38475978-37C338FF-4A3D-417F-98A7-DAC038E8C3EE Q53760093-27DECF2F-F2C7-4D6D-BA4A-7E17C84DC45A

P2860

Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014).

Item

http://www.wikidata.org/entity/Q38411478

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Melanocortin-4 receptor modula ...... a patent analysis (2008-2014).

@en

type

Item

label

Melanocortin-4 receptor modula ...... a patent analysis (2008-2014).

@en

prefLabel

Melanocortin-4 receptor modula ...... a patent analysis (2008-2014).

@en

P1476

Melanocortin-4 receptor modula ...... a patent analysis (2008-2014).

@en

P2093

Esther C Y Lee

http://www.w3.org/2001/XMLSchema#string

Philip A Carpino

http://www.w3.org/2001/XMLSchema#string

P2860

Central nervous control of energy and glucose balance: focus on the central melanocortin system

Discovery that a melanocortin regulates sexual functions in male and female humans

Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization

Melanocortins in the treatment of male and female sexual dysfunction

Effects of AgRP inhibition on energy balance and metabolism in rodent models

Melanocortin receptor 4 deficiency affects body weight regulation, grooming behavior, and substrate preference in the rat

Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.

Brain effects of melanocortins.

Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects

Genetic approaches to understanding human obesity.

P304

95-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/PPA.15.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25853469

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014).

about

P2860

P2860

Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921